. Author manuscript; available in PMC: 2014 Apr 1.

Published in final edited form as: J Low Genit Tract Dis. 2013 Apr;17(5 0 1):S64–S68. doi: 10.1097/LGT.0b013e3182854399

Table 2.

Cumulative 5-year risks of CIN3+ and cancer for women aged 21–24, 25–29, and 30–64 given Pap result and HPV test result for ASC-US. The overall ASC-US risks are for all ASC-US alone (regardless of HPV test result).

Baseline Pap and HPV test result	CIN3+ risk (%)			Cancer risk (%)
Baseline Pap and HPV test result	21–24	25–29	30–64	21–24	25–29	30–64
HSIL	28	28	47	0	2	7.3
ASC-H	16	24	18	0	1.5	2.6
AGC	6.9	14	8.5	1.1	1.1	2.7
LSIL	3	5	5.2	0	0	0.16
ASC-US	3	3.9	2.6	0.032	0.12	0.18
HPV-positive/ASC-US	4.4	7.1	6.8	0.055	0.16	0.41
HPV-negative/ASC-US	0.57	0.59	0.43	0	0.018	0.05
Pap-negative	0.2	0.36	0.26	0.004	0.027	0.011